Related Experiment Videos
Tocainide-induced reversible agranulocytosis and anemia
Archives of Internal Medicine
|March 1, 1987
Summary
Tocainide, an oral antiarrhythmic, can cause reversible bone marrow toxicity, including agranulocytosis and anemia. These hematologic issues resolved after discontinuing tocainide therapy in a patient.
Area of Science:
- Pharmacology
- Hematology
- Toxicology
Background:
- Tocainide is an established oral antiarrhythmic medication.
- Adverse hematologic effects are a known concern with some antiarrhythmic agents.